6.ALPHA.,9.ALPHA.-DIFLUORO-11.BETA.,16.ALPHA.,17.ALPHA.-TRIHYDROXY-21-MERCAPTOPREGNA-1,4-DIENE-3,20-DIONE-16,17-ACETONIDE-21-ACETATE
UNII UV7VVT86HA
Substance Identification & Data
This profile provides standardized clinical and technical data for 6.alpha.,9.alpha.-difluoro-11.beta.,16.alpha.,17.alpha.-trihydroxy-21-mercaptopregna-1,4-diene-3,20-dione-16,17-acetonide-21-acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UV7VVT86HA.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 33589-36-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H32F2O6S KUNWCOLNNIJDBE-IUGZLZTKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6.alpha.,9.alpha.-difluoro-11.beta.,16.alpha.,17.alpha.-trihydroxy-21-mercaptopregna-1,4-diene-3,20-dione-16,17-acetonide-21-acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.